发布求助
文献互助 智能选刊 最新文献

B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE最新文献

筛选
英文 中文
Once-Daily Single-Inhaler Versus Twice-Daily Multiple-Inhaler Triple Therapy: Two Replicate Trials in Patients with Chronic Obstructive Pulmonary Disease (COPD) 每日一次单吸入器与每日两次多吸入器三联治疗:慢性阻塞性肺疾病(COPD)患者的两项重复试验
B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4295
G. Ferguson, N. Brown, C. Compton, T. Corbridge, K. Dorais, C. Fogarty, C. Harvey, M. Kaisermann, D. Lipson, Neil Martin, F. Sciurba, M. Stiegler, Chang-Qing Zhu, D. Bernstein
{"title":"Once-Daily Single-Inhaler Versus Twice-Daily Multiple-Inhaler Triple Therapy: Two Replicate Trials in Patients with Chronic Obstructive Pulmonary Disease (COPD)","authors":"G. Ferguson, N. Brown, C. Compton, T. Corbridge, K. Dorais, C. Fogarty, C. Harvey, M. Kaisermann, D. Lipson, Neil Martin, F. Sciurba, M. Stiegler, Chang-Qing Zhu, D. Bernstein","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4295","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4295","url":null,"abstract":"","PeriodicalId":291780,"journal":{"name":"B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE","volume":"60 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127086326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Implications of Inhaler Device Selection Based Upon Peak Inspiratory Flow 基于峰值吸气流量的吸入器装置选择的意义
B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4301
Tarang Patel, E. Karle, A. Letvin, N. Epstein, R. Cheney, A. Krvavac
{"title":"The Implications of Inhaler Device Selection Based Upon Peak Inspiratory Flow","authors":"Tarang Patel, E. Karle, A. Letvin, N. Epstein, R. Cheney, A. Krvavac","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4301","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4301","url":null,"abstract":"","PeriodicalId":291780,"journal":{"name":"B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE","volume":"70 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128204831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Symptom Burden in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy 医疗保险优势COPD患者的症状负担开始使用乌莫替尼/维兰特罗或丙酸氟替卡松/沙美特罗治疗
B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4300
C. Moretz, B. Hahn, J. White, A. G. Hunter, B. Essoi, C. Elliott, Riju Ray
{"title":"Symptom Burden in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy","authors":"C. Moretz, B. Hahn, J. White, A. G. Hunter, B. Essoi, C. Elliott, Riju Ray","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4300","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4300","url":null,"abstract":"● Patients with ≥1 pharmacy claim for UMEC/VI OR FP/SAL 250mg during the 6 months closest to sample identification ● Age ≥65 as of calendar year 2017 ● Continuous Medicare Advantage enrolment during the 12-month baseline period ● ≥2 ICD-10-CM COPD diagnosis codes at least 30 days apart during the 12-month baseline period ● Patients with evidence of UMEC/VI AND/OR FP/SAL during 6 months prior to the study criteria period ● Patients with evidence of triple therapy during the 12-month baseline period ● Patients with ≥1 asthma ICD-10 diagnosis codes during the 12-month baseline period ● Diagnosis or treatment for lung cancer ● Missing or invalid demographic or insurance information","PeriodicalId":291780,"journal":{"name":"B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE","volume":"87 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131696651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrepid: Clinical Effectiveness of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Versus Multiple-Inhaler Triple Therapy in Usual Clinical Practice 每日一次单吸入器糠酸氟替卡松/乌莫克利地铵/维兰特罗与常规临床实践中多吸入器三联治疗的临床疗效
B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4313
D. Halpin, S. Worsley, A. Ismaila, J. Astrom, K. Beeh, D. Brintziki, V. D. Boscio, J. Kocks, J. Marin, M. Tabberer, N. Snowise, C. Compton
{"title":"Intrepid: Clinical Effectiveness of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Versus Multiple-Inhaler Triple Therapy in Usual Clinical Practice","authors":"D. Halpin, S. Worsley, A. Ismaila, J. Astrom, K. Beeh, D. Brintziki, V. D. Boscio, J. Kocks, J. Marin, M. Tabberer, N. Snowise, C. Compton","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4313","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4313","url":null,"abstract":"1University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK; 2GSK, Stevenage, Hertfordshire, UK; 3GSK, Collegeville, PA, USA; 4McMaster University, Hamilton, ON, Canada; 5GSK, Värmdö, Stockholm, Sweden; 6insaf Respiratory Research Institute, Wiesbaden, Germany; 7GSK, Stockley Park West, Uxbridge, Middlesex, UK; 8GSK, Brentford, Middlesex, UK; 9General Practitioners Research Institute, Groningen, the Netherlands; 10University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, the Netherlands; 11Observational and Pragmatic Research Institute, Singapore; 12University Hospital Miguel Servet, Zaragoza, Spain; 13King’s College, London, UK","PeriodicalId":291780,"journal":{"name":"B103. TREATMENT OF OBSTRUCTIVE LUNG DISEASE","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133293539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信